# Ginsenoside Rb1 **Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/ginsenoside-rb1 **Data Source:** Hermetica Superfoods Ingredient Encyclopedia **Updated:** 2026-03-19 **Evidence Score:** 6 / 10 **Category:** Compound **Also Known As:** (3β,12β)-3-[O-β-D-glucopyranosyl-(1→2)-β-D-glucopyranosyl]oxy-12-hydroxydammar-24-en-20-yl O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranoside, Rb1, Ginsenoside-Rb1, 20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol-3-O-β-D-glucopyranosyl(1→2)-β-D-glucopyranoside, Protopanaxadiol-type ginsenoside Rb1, Panax saponin Rb1 ## Overview Ginsenoside Rb1 is a major triterpenoid saponin found in ginseng root that acts primarily through cAMP-dependent protein kinase pathways. This bioactive compound demonstrates [neuroprotective](/ingredients/condition/cognitive), [anti-inflammatory](/ingredients/condition/inflammation), and anti-obesity effects in preclinical studies. ## Health Benefits • Neuroprotective effects through modulation of [neurotransmitter release](/ingredients/condition/cognitive) via cAMP-dependent protein kinase pathway (preclinical evidence only) • [Anti-inflammatory](/ingredients/condition/inflammation) properties demonstrated in laboratory studies (no human clinical data available) • Anti-obesity potential shown in preclinical models (human studies lacking) • Immunostimulatory activity observed in vitro (clinical evidence absent) • Anticancer effects including apoptosis inhibition noted in cell studies (no human trial data) ## Mechanism of Action Ginsenoside Rb1 activates cAMP-dependent protein kinase A (PKA) pathways, leading to phosphorylation of CREB transcription factors. This modulates [neurotransmitter release](/ingredients/condition/cognitive), particularly [dopamine](/ingredients/condition/mood) and acetylcholine, while inhibiting [pro-inflammatory cytokine](/ingredients/condition/inflammation)s like TNF-α and IL-6. The compound also influences lipid [metabolism](/ingredients/condition/weight-management) through activation of AMPK signaling pathways. ## Clinical Summary Current evidence for Ginsenoside Rb1 is limited to preclinical laboratory and animal studies. In vitro studies demonstrate [neuroprotective effect](/ingredients/condition/cognitive)s at concentrations of 10-100 μM, while rodent studies show [anti-inflammatory](/ingredients/condition/inflammation) responses at doses of 20-40 mg/kg. No human clinical trials specifically examining isolated Ginsenoside Rb1 have been published. Most human data comes from whole ginseng extract studies containing multiple ginsenosides. ## Nutritional Profile Ginsenoside Rb1 is a purified triterpenoid saponin compound (not a whole food), so conventional macronutrient/micronutrient profiling does not apply. Molecular formula: C54H92O23, molecular weight: 1109.3 g/mol. It is a dammarane-type tetracyclic triterpenoid glycoside with two glucose units attached at C-3 and C-20 positions of the protopanaxadiol aglycone backbone. Typical concentration in Panax ginseng root: 1–10 mg/g dry weight (varies by species, age, and plant part; root tip concentrations can reach up to 15 mg/g). In standardized ginseng extracts, Rb1 commonly constitutes 20–40% of total ginsenoside content. As an isolated compound, it contains no meaningful protein, fat, fiber, vitamins, or minerals. Bioavailability is notably poor via oral administration: intestinal absorption of intact Rb1 is minimal (<1% in some studies), as it undergoes extensive biotransformation by gut microbiota into active metabolites including compound K (20-O-beta-(D-glucopyranosyl)-20(S)-protopanaxadiol), which is the primary absorbable form with estimated bioavailability of 10–20% depending on [gut microbiome](/ingredients/condition/gut-health) composition. Peak plasma concentration of metabolites occurs approximately 6–12 hours post-ingestion. Lipophilicity (logP approximately 1.2) limits passive diffusion; transporter-mediated uptake (OATP family) is proposed. No caloric contribution is relevant at pharmacologically studied doses (typically 20–100 mg in preclinical models; human dose equivalents not firmly established). ## Dosage & Preparation No clinically studied dosage ranges have been established for ginsenoside Rb1 in humans, as clinical trial data is absent from the scientific literature. Consult a healthcare provider before starting any new supplement. ## Safety & Drug Interactions Safety data for isolated Ginsenoside Rb1 in humans is limited due to lack of clinical trials. As a ginseng component, it may interact with anticoagulant medications and blood sugar-lowering drugs. Potential side effects based on ginseng research include [insomnia](/ingredients/condition/sleep), headaches, and gastrointestinal upset. Safety during pregnancy and breastfeeding has not been established. ## Scientific Research The research dossier reveals a significant gap in human clinical evidence for ginsenoside Rb1, with no RCTs, meta-analyses, or human trials documented. All available data comes from preclinical (in vitro/in vivo) studies examining [neuroprotective](/ingredients/condition/cognitive), [anti-inflammatory](/ingredients/condition/inflammation), and other biological activities. ## Historical & Cultural Context While ginsenoside Rb1 is noted as a major active constituent of Panax ginseng, the research provides no specific historical or traditional medicine context for this isolated compound. Traditional uses of the parent plant are referenced but not detailed. ## Synergistic Combinations Other ginsenosides, Panax ginseng extract, American ginseng, [adaptogenic herb](/ingredients/condition/stress)s ## Frequently Asked Questions ### What is the typical dosage of ginsenoside rb1 in supplements? Most ginseng supplements contain 2-10 mg of ginsenoside Rb1 per serving as part of standardized extracts. Pure Ginsenoside Rb1 supplements are rare, with research suggesting effective doses of 20-40 mg/kg in animal studies. ### How long does it take for ginsenoside rb1 to work? Based on pharmacokinetic studies, Ginsenoside Rb1 reaches peak blood levels 2-4 hours after oral administration. However, therapeutic effects on inflammation and neuroprotection may require weeks of consistent supplementation based on ginseng research. ### Can ginsenoside rb1 cross the blood-brain barrier? Ginsenoside Rb1 has limited ability to cross the blood-brain barrier intact due to its large molecular weight. However, it may be metabolized by gut bacteria into smaller compounds like compound K that can reach brain tissue. ### Is ginsenoside rb1 better than other ginsenosides? Ginsenoside Rb1 shows unique neuroprotective properties through cAMP pathways, while Rg1 demonstrates different cardiovascular benefits. Research suggests synergistic effects occur when multiple ginsenosides are combined rather than using isolated compounds. ### What foods naturally contain ginsenoside rb1? Ginsenoside Rb1 is found primarily in Panax ginseng root, with concentrations of 0.2-2% by weight depending on age and processing. Red ginseng typically contains higher levels than white ginseng due to steaming processing methods. ### What does the research evidence show about ginsenoside Rb1's effectiveness in humans? Most evidence for ginsenoside Rb1 comes from laboratory and animal studies, which show promise for neuroprotection, anti-inflammatory, and immune-supporting effects. Human clinical trials are limited, making it difficult to confirm these benefits translate to real-world supplementation. The gap between preclinical findings and human data means claims about its efficacy should be viewed as preliminary rather than established. ### Does ginsenoside Rb1 interact with common medications? While ginsenoside Rb1 has immunostimulatory properties in laboratory settings, specific drug interaction data in humans is scarce. Because it may influence immune function and inflammatory pathways, caution is warranted if taking immunosuppressants or anti-inflammatory medications, though clinical evidence of actual interactions is lacking. Consulting a healthcare provider before combining ginsenoside Rb1 with prescription medications is recommended. ### Who should consider taking ginsenoside Rb1 supplements and who should avoid it? Ginsenoside Rb1 may interest individuals seeking cognitive support or immune function enhancement based on preclinical evidence, though human data is limited. Those with autoimmune conditions should exercise caution due to its immunostimulatory effects observed in vitro. Pregnant, nursing, or very young individuals should avoid supplementation due to insufficient safety data in these populations. --- *Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com* *License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*